America First Investment Advisors’s GSK GSK Stock Holding History

America First Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-400	Closed	-$15.4K	–	55
2024 Q2	$15.4K	Hold	400	–	–	﹤0.01%	70
2024 Q1	$17.1K	Hold	400	–	–	﹤0.01%	71
2023 Q4	$14.8K	Hold	400	–	–	﹤0.01%	86
2023 Q3	$14.5K	Hold	400	–	–	﹤0.01%	83
2023 Q2	$14.3K	Hold	400	–	–	﹤0.01%	87
2023 Q1	$14.2K	Hold	400	–	–	﹤0.01%	85
2022 Q4	$14K	Hold	400	–	–	﹤0.01%	72
2022 Q3	$12K	Hold	400	–	–	﹤0.01%	65
2022 Q2	$22K	Hold	400	–	–	0.01%	56
2022 Q1	$22K	Hold	400	–	–	0.01%	61
2021 Q4	$22K	Buy	+400	New	+$20.8K	0.01%	61
2016 Q2	–	Sell	-198	Closed	-$10K	–	116
2016 Q1	$10K	Buy	+198	New	+$9.86K	﹤0.01%	99

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

America First Investment Advisors's GSK Position: Q3 2024 in Review

America First Investment Advisors sold out of GSK (GSK) in Q3 2024, closing a stake of 400 shares — an estimated $15.4K sold.

America First Investment Advisors first reported a position in GSK in Q1 2016 and held it in 12 quarters. The position peaked at $22K in Q2 2022. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

America First Investment Advisors reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
America First Investment Advisors sold 400 GSK shares in Q3 2024, an estimated $15.4K.
America First Investment Advisors first reported a position in GSK in Q1 2016 and held it in 12 quarters.
America First Investment Advisors's GSK position peaked at $22K in Q2 2022.
899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on America First Investment Advisors's 13F filing for Q3 2024, filed 8 Nov 2024.